Novogen, World Leader in Isoflavone Research
Novogen is the Australian biotechnology company which has patented isoflavone technology for the treatment and prevention of degenerative diseases and disorders. Over the past ten years, Novogen has conducted the largest and most comprehensive isoflavone clinical testing programs in the world. Novogen is dedicated to growing its knowledge of how isoflavones provide benefits for human health. Novogen brands and products are a direct result of the Company’s ongoing research programs. The research programs are conducted around the world and co-ordinated from its head office in Sydney Australia.
Novogen has identified red clover as the most potent source of isoflavones and as a result red clover isoflavones are the basis of Promensil and Trinovin ranges. Promensil is a range of natural products specifically for women’s health and Trinovin is a natural product specifically for men’s midlife health.
Novogen consumer brands,
Promensil and
Trinovin are available around the world. All products are supported by published clinical research and manufactured under strict pharmaceutical manufacturing standards.
Based on Novogen’s pioneering research the Company has seen patents for its consumer products issued in Australia, USA, Canada, UK and Europe. Novogen considers Intellectual Property as a key corporate asset and will endeavour to protect it’s IP at all times.
Novogen Consumer has developed global sales and marketing expertise in the development of clinically proven, unique health products that require medical, consumer and retail communications and management. As a result the Novogen Consumer product portfolio is expanding from internal development and licensing from companies with a similar philosophy of developing clinically proven, natural products.
Vinalac, is scientifically proven to support the natural immune system and health of a pregnant mother and baby. Vinalac contains vitamins, minerals and a probiotic to help the development of a healthy baby and to help prevent childhood allergies, including eczema, in children at risk of allergy.
